Chinthalapally V Rao Selected Research

Proliferating Cell Nuclear Antigen (PCNA)

1/2021	Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice.
11/2019	Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma.
1/2016	Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice.
12/2015	Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.
10/2015	Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma.
8/2014	Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression.
7/2014	Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice.
3/2014	Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.
1/2014	Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis.
12/2013	Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chinthalapally V Rao Research Topics

Disease

89	Neoplasms (Cancer) 11/2022 - 01/2002
47	Carcinogenesis 01/2022 - 01/2002
41	Colonic Neoplasms (Colon Cancer) 11/2021 - 01/2002
21	Adenocarcinoma 11/2021 - 01/2004
21	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2008
18	Aberrant Crypt Foci 01/2014 - 01/2002
17	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2002
15	Inflammation (Inflammations) 10/2021 - 08/2004
11	Body Weight (Weight, Body) 01/2022 - 01/2002
11	Carcinoma (Carcinomatosis) 11/2021 - 01/2002
11	Adenoma (Adenomas) 11/2021 - 01/2002
10	Polyps 08/2018 - 02/2004
8	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2022 - 01/2002
8	Carcinoma in Situ 11/2017 - 11/2010
6	Adenocarcinoma of Lung 05/2021 - 09/2013
6	Intestinal Polyps 03/2014 - 07/2006
5	Genomic Instability 11/2022 - 03/2005
5	Lung Neoplasms (Lung Cancer) 01/2021 - 07/2006
4	Transitional Cell Carcinoma 01/2016 - 08/2013
3	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 01/2018
3	Urinary Bladder Neoplasms (Bladder Cancer) 07/2014 - 11/2009
3	Breast Neoplasms (Breast Cancer) 08/2013 - 02/2004
2	AIDS-Related Complex (ARC) 10/2020 - 01/2018
2	Edema (Dropsy) 01/2020 - 06/2006

Drug/Important Bio-Agent (IBA)

29	AzoxymethaneIBA 11/2021 - 01/2002
17	Pharmaceutical PreparationsIBA 01/2022 - 05/2008
15	Celecoxib (Celebrex)FDA Link 01/2022 - 01/2002
15	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2021 - 06/2006
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2002
11	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 01/2002
11	Biomarkers (Surrogate Marker)IBA 05/2021 - 02/2005
11	CytokinesIBA 01/2021 - 11/2004
11	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2020 - 01/2002
10	CarcinogensIBA 11/2021 - 01/2002
9	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020 - 01/2002
8	EnzymesIBA 01/2022 - 04/2002
7	Cyclin D1IBA 01/2021 - 11/2011
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2019 - 01/2002
7	licofeloneIBA 08/2018 - 12/2011
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2016 - 04/2006
7	CP 31398IBA 01/2015 - 09/2008
7	Atorvastatin (Lipitor)FDA Link 05/2013 - 10/2005
6	Naproxen (Naprosyn)FDA LinkGeneric 01/2022 - 11/2009
6	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2020 - 01/2002
6	Lipoxygenase (Lipoxygenase-1)IBA 07/2014 - 01/2007
6	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2011 - 01/2002
5	PhytochemicalsIBA 01/2022 - 01/2002
5	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2008
5	Oxidoreductases (Dehydrogenase)IBA 12/2020 - 04/2002
5	CateninsIBA 12/2020 - 11/2011
5	Caspase 3 (Caspase-3)IBA 11/2019 - 04/2002
5	ProstaglandinsIBA 01/2013 - 01/2002
4	Dinoprostone (PGE2)FDA Link 01/2022 - 06/2006
4	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 08/2018 - 01/2002
4	PolyaminesIBA 11/2016 - 12/2014
4	Eflornithine (Ornidyl)FDA Link 11/2016 - 10/2005
4	Gefitinib (Iressa)FDA Link 01/2016 - 11/2010
4	Caveolin 1IBA 05/2013 - 05/2004
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2012 - 01/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2012 - 02/2004
4	Messenger RNA (mRNA)IBA 02/2012 - 01/2002
4	CurcuminIBA 03/2009 - 01/2002
3	AcidsIBA 11/2021 - 02/2004
3	ErbB Receptors (EGF Receptor)IBA 12/2020 - 11/2010
3	Amyloid (Amyloid Fibrils)IBA 10/2020 - 01/2018
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 12/2013
3	CholesterolIBA 01/2020 - 08/2004
3	Amyloid beta-PeptidesIBA 01/2020 - 01/2018
3	Histones (Histone)IBA 01/2018 - 11/2009
3	(((4- nitrophenyl)amino)(2,2,4,4- tetramethyl thiochroman-6-yl)amino) methane-1-thioneIBA 01/2018 - 07/2012
3	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 10/2015 - 12/2011
3	InterleukinsIBA 10/2015 - 06/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 08/2013
3	Raloxifene Hydrochloride (Evista)FDA Link 03/2014 - 01/2009
3	Estrogen ReceptorsIBA 03/2014 - 01/2009
3	TriterpenesIBA 10/2013 - 06/2006
3	SaponinsIBA 10/2013 - 08/2004
3	Corn Oil (Oil, Corn)IBA 01/2013 - 01/2002
3	Transcription Factors (Transcription Factor)IBA 01/2013 - 03/2011
3	Protein Isoforms (Isoforms)IBA 01/2013 - 01/2002
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2012 - 02/2004
3	LipidsIBA 12/2011 - 09/2005
3	glutaryl-coenzyme A (glutaryl-CoA)IBA 11/2009 - 04/2002
3	Fish OilsIBA 01/2008 - 01/2002
2	AntioxidantsIBA 01/2022 - 01/2017
2	CaspasesIBA 01/2022 - 11/2004
2	Omeprazole (Prilosec)FDA LinkGeneric 11/2021 - 01/2012
2	Proton Pump InhibitorsIBA 11/2021 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 06/2009
2	EicosanoidsIBA 10/2021 - 12/2012
2	Prostaglandin-E SynthasesIBA 12/2020 - 07/2014
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 12/2020 - 12/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2020 - 01/2012
2	Coenzyme A (CoA)IBA 12/2020 - 07/2006

Therapy/Procedure

31	Chemoprevention 05/2021 - 01/2002
11	Therapeutics 11/2022 - 01/2008
5	Drug Therapy (Chemotherapy) 05/2021 - 11/2009
5	Injections 01/2009 - 01/2002
2	Oral Administration 01/2022 - 09/2013
2	Immunomodulation 05/2021 - 08/2017